Royal Philips has launched a multi-component solution, dubbed VitalMinds, as a non-pharmacological method for reducing delirium in intensive care unit (ICU) patients.

The solution involves a CE marked personalised light therapy system called VitalSky, which offers a circadian-effective programme to support the patients’ sleep-wake rhythm.

This programme uses a spectrum of glare-free white light to simulate the natural progression of daylight. The light is provided by a luminous LED ceiling and can be customised based on the requirements of the individual patient.

“With VitalMinds, we have developed a new concept that combines light and sound management, circadian-effective light therapy, staff training and consulting services.”

The system offers the additional option of playing calming nature scenes in full-colour and soft-focus video. In the future, the system may also enable cognitive training.

The different programmes and settings of the system can be regulated using a portable user interface.

Royal Philips Monitoring Analytics business leader Felix Baader said: “With VitalMinds, we have developed a new concept that combines light and sound management, circadian-effective light therapy, staff training and consulting services, to help hospitals reduce delirium and improve patient recovery in the ICU.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

“This integrated approach is based on international ICU guidelines and supports hospitals in achieving the quadruple aim to improve patient and staff experience, deliver better health outcomes, and drive lower costs in intensive care medicine.” 

The system is currently available in Germany, Austria, Switzerland, Finland and Sweden. Additional roll-outs across other European countries will be carried out over the next two years.